Ascend Wellness (OTCMKTS:AAWH – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.01), Zacks reports.
Ascend Wellness Stock Performance
Shares of OTCMKTS AAWH traded down $0.02 during mid-day trading on Thursday, reaching $0.35. The company had a trading volume of 187,924 shares, compared to its average volume of 107,959. Ascend Wellness has a one year low of $0.34 and a one year high of $1.20. The business’s 50-day simple moving average is $0.46 and its 200 day simple moving average is $0.49. The firm has a market cap of $71.10 million, a price-to-earnings ratio of -0.61 and a beta of 1.22.
About Ascend Wellness
Ascend Wellness Holdings, Inc. is a vertically integrated cannabis company that cultivates, manufactures, and sells cannabis products in the United States. The company serves both medical and adult-use markets, subject to applicable state regulations. Ascend’s product portfolio includes flower, pre-rolls, vapes, concentrates, edibles, and other cannabis products sold under brands such as Ozone, Simply Herb, Common Goods, and &Shine. The company distributes products through its own retail dispensaries and through wholesale channels serving third-party cannabis retailers.
See Also
- Five stocks we like better than Ascend Wellness
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
Receive News & Ratings for Ascend Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascend Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
